At a glance
ClinicalIndex Comparison RecordN/ACompleted· 30 enrolled
Drug / intervention
Laser treatmentdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Investigation to Assess the Safety and Efficacy of the Laser for the Treatment of Vulvovaginal Atrophy
In Brief
A clinical study evaluating Laser treatment for Vulvovaginal Atrophy. Completed, enrolled 30 participants across 2 sites.
Detailed Summary
The purpose of this study is to assess the safety and the efficacy of a laser in the treatment of vulvovaginal atrophy (VVA), that is to assess the change in the severity of the vaginal dryness symptom, by means of a visual analogic scale (10 cm VAS).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVulvovaginal Atrophy
CountriesUnited States
CollaboratorsThe Christ Hospital, Stanford University
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartMar 2014
First PostedMar 2014
Primary CompletionAug 2015
Study CompletionNov 2015
TodayJul 2026
First PostedMar 13, 2014
Enrollment StartMar 1, 2014
Primary CompletionAug 1, 2015
Study CompletionNov 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 12.3 years ago
Interventions
Laser treatmentdevice
The laser handpiece (probe) will be deposited in the vaginal canal and the laser energy will be delivered through the handpiece